Advancing Skin Cancer Detection: PathGroup’s Specialized Dermatology and Dermatopathology Services

May marks Skin Cancer Awareness Month, a pivotal time for healthcare professionals and patients to focus on education, prevention, and the critical importance of early detection. With skin cancer remaining the most common form of cancer in the United States, the role of accurate, timely, and specialized diagnostic services cannot be overstated. For medical practices, having a reliable laboratory partner is essential to managing patient care effectively. PathGroup provides a robust infrastructure of dermatopathology services, combining the expertise of board-certified specialists with advanced technology to support physicians in diagnosing and treating skin conditions ranging from inflammatory disorders to complex melanomas.

The Critical Role of Specialized Dermatopathology

Dermatopathology is a subspecialty of pathology focused on the study of cutaneous diseases at a microscopic level. While general pathology covers a broad spectrum of anatomy, the intricacies of the skin require a focused approach. Skin tissue can present with thousands of different conditions, many of which share similar histological features. Distinguishing between a benign nevus and a dysplastic nevus, or identifying the subtle signs of early-stage melanoma, requires the eye of a fellowship-trained dermatopathologist.

Through its specialized divisions, including DermPathGroup and regional partners like ADPA (Atlanta Dermatopathology), PathGroup Labs offers dedicated expertise in this field. These services are designed to function as an extension of the dermatology practice, providing high-quality diagnostic interpretations that guide clinical decision-making. The laboratory employs a physician-led model, ensuring that every specimen is reviewed with clinical precision and that ordering physicians have direct access to the pathology team for consultation on complex cases.

Comprehensive Diagnostic Capabilities for Skin Cancer

Effective skin cancer management relies on a comprehensive menu of testing options. PathGroup’s dermatology services encompass a wide array of diagnostic techniques, from routine histology to advanced molecular profiling. The laboratory is equipped to handle biopsies for Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC), Melanoma, and Merkel Cell Carcinoma, as well as a vast range of non-neoplastic skin disorders.

Anatomic and Histological Analysis

The foundation of skin cancer diagnosis is the examination of tissue samples under a microscope. PathGroup utilizes advanced processing techniques to ensure high-quality slide preparation. This includes routine Hematoxylin and Eosin (H&E) staining, which allows pathologists to visualize the tissue structure and cellular details. When standard staining is insufficient for a definitive diagnosis, the laboratory employs a robust menu of special stains and immunohistochemistry (IHC) markers.

For example, in cases where melanoma is suspected but morphologically ambiguous, markers such as SOX10, HMB-45, and Melan-A can be utilized to confirm the melanocytic origin of tumor cells. This level of detail is crucial for accurate staging and treatment planning. The dermatopathology team works closely with clinicians to correlate histological findings with clinical presentations, ensuring the highest level of diagnostic accuracy.

Direct Immunofluorescence (DIF)

Beyond tumor diagnostics, PathGroup offers Direct Immunofluorescence (DIF) testing. This technique is vital for diagnosing autoimmune blistering diseases and connective tissue disorders, such as Pemphigus Vulgaris or Lupus Erythematosus, which can sometimes mimic other skin conditions. By detecting antibodies bound to proteins in the skin, DIF provides definitive answers that guide immunosuppressive therapies.

Molecular Intelligence in Dermatology

As the understanding of skin cancer biology evolves, molecular testing has become increasingly important, particularly for advanced melanomas. PathGroup integrates molecular oncology capabilities directly into the diagnostic workflow. Identification of specific genetic mutations, such as BRAF, NRAS, or c-KIT, can determine a patient’s eligibility for targeted therapies. This integrated approach aligns with the “One Lab. Total Service” philosophy, allowing clinicians to order routine pathology and complex molecular testing through a single source, thereby streamlining the pathway from diagnosis to treatment.

Leveraging Digital Pathology and Technology

The field of pathology is undergoing a digital transformation, and PathGroup is at the forefront of this shift. Digital pathology involves scanning glass slides to create high-resolution digital images. This technology facilitates rapid second opinions and intradepartmental consultations. Instead of physically shipping glass slides between locations, pathologists can share images instantly, ensuring that difficult cases receive input from sub-specialists regardless of their physical location.

To further support efficiency in dermatology practices, the laboratory utilizes PathConnect™, a proprietary web-based platform. This system simplifies the ordering process and provides real-time access to reports. For dermatologists performing multiple biopsies on a single patient, the ability to view cumulative reports and historical trends is invaluable. The interface is designed to integrate with over 200 different Electronic Health Records (EHR) and Practice Management Systems (PMS), minimizing administrative burdens and reducing the risk of data entry errors.

A Physician-Led Approach to Patient Care

The distinction of PathGroup lies in its physician leadership. The laboratory is not merely a testing facility but a medical practice composed of over 190 pathologists representing all subspecialties. This leadership structure ensures that clinical quality remains the primary focus. Dermatopathologists are encouraged to communicate directly with ordering providers to discuss discordant findings or clarify clinical questions. This open line of communication is vital in dermatology, where clinical-pathologic correlation is often required to arrive at the correct diagnosis.

Furthermore, the laboratory operates 24 hours a day, seven days a week, to ensure industry-leading turnaround times. For a patient waiting to hear if a lesion is benign or malignant, every day matters. By optimizing workflow and logistics, the laboratory strives to deliver results as quickly as possible without compromising quality.

Supporting the Total Patient Journey

While the primary focus during Skin Cancer Awareness Month is often on the biopsy itself, patient care involves a broader spectrum of laboratory needs. Because PathGroup is a full-service laboratory, dermatology practices can rely on the same partner for clinical laboratory testing. This includes pre-operative blood work, liver function tests for patients on systemic medications (such as isotretinoin or methotrexate), and monitoring for biologics.

The laboratory also prioritizes the patient experience regarding access and billing. Through the MyResults™ portal, patients can securely access their lab results, empowering them to take an active role in their healthcare journey. Additionally, the billing department works with over 400 insurance providers and offers patient advocate services to assist with financial questions. This comprehensive support system helps alleviate the anxiety often associated with medical testing.

Commitment to Quality and Accessibility

Serving over 15,000 healthcare providers across 25 states, PathGroup maintains a rigorous Quality Assurance program accredited by the College of American Pathologists (CAP). The commitment to quality extends from the moment a specimen is collected to the final delivery of the report. For dermatology practices, this reliability translates to confidence in every diagnosis rendered.

As the medical community observes Skin Cancer Awareness Month, the focus remains on saving lives through early detection and precise treatment. By partnering with a laboratory that combines specialized dermatopathology expertise, advanced molecular capabilities, and a physician-centric service model, healthcare providers are better equipped to navigate the complexities of skin disease and improve outcomes for their patients.

About PathGroup

PathGroup delivers full-service diagnostic excellence through anatomic, clinical, and molecular pathology—backed by physician leadership and cutting-edge digital technologies. With 24/7 operations and rapid turnaround times, we empower hospitals and physicians with faster, more accurate results that drive better patient outcomes. Trusted by over 250 hospitals nationwide, our integrated approach ensures seamless testing, expert interpretation, and a commitment to clinical precision at every step.

Stay connected with PathGroup and our regional locations on social media:
Facebook,
LinkedIn,
Brentwood TN,
Johnson City TN,
Nashville TN,
Chattanooga TN (McCallie Ave),
Chattanooga TN (Brainerd Rd),
Cleveland TN,
Cookeville TN,
Hendersonville TN,
Madison TN,
McMinnville TN,
Murfreesboro TN,
Nashville TN (Murphy Ave),
Smyrna TN,
Tullahoma TN,
White House TN,
Huntsville AL,
Birmingham AL,
Sylacauga AL,
Athens GA,
Atlanta GA,
Jesup GA, and
Brunswick GA.